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Biosynthesis of thiomarinol A and related
metabolites of Pseudoalteromonas sp. SANK 73390†
Annabel C. Murphy,‡§a Shu-Shan Gao,‡a Li-Chen Han,a Simon Carobene,a
Daisuke Fukuda,bc Zhongshu Song,a Joanne Hothersall,b Russell J. Cox,a
John Crosby,a Matthew P. Crump,a Christopher M. Thomas,b Christine L. Willis*a
and Thomas J. Simpson*a
The biosynthesis of themixed PKS-FAS-NRPS hybrid antibiotic thiomarinol A was investigated using feeding
studies to both wild type and mutant strains of the marine bacterium Pseudoalteromonas. Particularly
interesting features of the pathway include assembly of the 8-hydroxyoctanoic acid side-chain via chain
extension of a C4-precursor (4-hydroxybutyrate), and construction of the pyrrothine unit from cysteine
via (HolA-D, F-H) prior to intact incorporation into thiomarinol (catalysed by TmlU). A series of
thiomarinol-related and other minor metabolites have been isolated from wild-type and mutant strains.
The results of these investigations are rationalised in terms of the overall biosynthetic pathway.
Introduction
Thiomarinol A 1 (Fig. 1), is the major metabolite produced by
the marine bacterium Pseudoalteromonas sp. SANK 73390, along
with minor analogues B to G (2 to 7).1–3 They display antibiotic
activity against both Gram-negative and Gram-positive bacteria,
and have particularly potent activity against methicillin-resis-
tant Staphylococcus aureus (MRSA). They are unusual in being
hybrid antibiotics, eﬀectively two separate antibiotic classes in
one molecule, and biosynthetically can be regarded as
comprising three main elements: a highly functionalised poly-
ketide-derived acid, which is esteried by a hydroxy fatty acid,
which itself forms an amide with the bicyclic amino acid-
derived pyrrothine. The main carbon skeleton of the thiomar-
inols is very closely related to that of mupirocin, an important
antibiotic used clinically against MRSA.4 Mupirocin consists of
a mixture of pseudomonic acids (PA A–C, 8 to 10),5–7 with PA-A
comprising ca. 95% of the mixture. The major diﬀerences in
thiomarinol A are the replacement of the 9-hydroxynonanoic
acid moiety in the PAs with 8-hydroxyoctanoate in the
thiomarinols, the presence of an extra 4-hydroxyl group, the
lack of the 10,11-epoxide and the pyrrothine. Many pyrrothine
natural products themselves display antibiotic activity, e.g.
holomycin 11, N-propionylholothin 12, thiolutin 13, and aur-
eothricin 14.8–10 Stable isotope labelling studies were used to
conrm the origins of all of the atoms in pseudomonic acid A
and were consistent with a polyketide/fatty acid origin.11,12
This was subsequently conrmed by isolation of the biosyn-
thetic gene cluster13 which revealed that mupirocin was one of
the rst members of what is now known to comprise an
increasingly large number of biologically active compounds.
These are most oen from diverse and unusual bacterial
sources and are produced via trans-AT modular PKSs that have
evolved independently from other modular systems.14 The
main identifying feature of these systems is the lack of an
integral acyl transferase (AT) domain in each chain extension
module, this function being supplied “in trans” to each
module by separately encoded mono- (or di-) functional ATs.
In addition they show many other unusual features including
extensive involvement of other trans acting enzymes during
polyketide assembly. In particular b-branches are introduced
onto b-keto–thiol ester intermediates by a cassette of enzymes
that include an HMG CoA synthase (HMGS) analogue using
chemistry similar to that involved in mevalonate formation in
terpene biosynthesis.15 The biosynthesis of the pyrrothine
class of natural products has not been studied in detail,
although cysteine has been implicated as a precursor via radio-
isotope labelling studies.16
We have recently identied the thiomarinol (tml) biosyn-
thetic gene cluster via full genome sequencing of SANK 73390. It
is contained on a 97 kb plasmid consisting almost entirely of
the thiomarinol biosynthetic genes.17 These consist of trans-AT
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PKSs (tmpA, C and D), a putative FAS (tmpB) and associated
tailoring and resistance genes (tmlA-Z) with high homology to
the mupirocin (mup) cluster (Fig. S1, ESI†). A non-ribosomal
peptide synthetase (NRPS) linked to a set of tailoring enzymes
(holA-H) is also present similar to that recently shown to control
holomycin biosynthesis in Streptomyces clavuligerus.18,19 Anal-
ysis of the WT culture and mutant strains in which the PKS and
NRPS parts of the cluster had been deactivated by in-frame
deletions, resulted in isolation of a number of new thiomarinol
related compounds.20 Analysis of extracts of the WT strain by
reversed-phase HPLC-ESIMS led to the isolation of two addi-
tional polar metabolites which lacked the pyrrothine moiety.
These were shown to be marinolic acid A 15 and the corre-
sponding amide, marinolic amide 16. Similar analysis of the
DNRPS mutant strain showed, as expected, that no pyrrothine
containing compounds were produced, the major thiomarinol
metabolite being marinolic acid A, but no amide 16. Two minor
metabolites were isolated: marinolic acid A6 17 and A4 18 in which
the octanoate moiety on marinolic acid A has been replaced
by hexanoate and butanoate respectively. Re-examination of
the WT extracts revealed trace amounts of 17. A number of new
acyl-pyrrothine containing compounds were also isolated. On the
basis of their similarity tometabolites previously isolated21–23 from
Xenorhabdus spp, they were designated as xenorhabdins 8–13
(19–25) respectively (Fig. 2).
We now report stable isotope labelling and other feeding
experiments with WT and mutant strains of Pseudoalteromonas
which conrm the origins of all of the atoms in thiomarinol,
provide a rationalisation for the occurrence of the minor related
metabolites, and for the timing of pyrrothine formation and its
linkage to marinolic acid.
Results and discussion
The 13C NMR spectrum of thiomarinol A was rigorously
assigned. This necessitated reassignment of two side-chain
carbons (C40 and C50) compared to that made previously.1 This
was achieved using a high resolution band-selective HMBC
experiment with correlations observed via H30 (to C40 and C50)
and H70 (to C60 and C50) allowing these two carbons, which are
separated by 0.1 ppm, to be unambiguously assigned. In
d6-DMSO, the 15- and 17-methyls are coincident, but they are
resolved in d4-methanol. Prior to stable-isotope labelled
precursor feeding, the production of thiomarinol A was moni-
tored. This showed that thiomarinol production commences at
around 7 hours aer the start of fermentation, reaches a
maximum around 24 hours and levels then slowly decrease
thereaer. The labelled precursors were therefore fed to the
fermentation media ca. 7 hours aer inoculation, and
the fermentation extracted aer 24 hours. The crude extract
obtained was puried to give thiomarinol A, which was then
analysed by 13C NMR to determine the extent and positions of
13C and 18O incorporations. The results of feeding labelled
acetates and [methyl-13C]-methionine to wild-type Pseudoalter-
omonas SANK 73390 are summarised in Scheme 1.
The incorporation pattern conrms the similarity of the
pseudomonic acid A11,12 and thiomarinol A biosynthetic
Fig. 2 Marinolic acid and acyl-pyrrothine metabolites isolated from
WT and mutant strains.
Fig. 1 Thiomarinol, pseudomonic acid and acyl pyrrothine antibiotics.
Scheme 1 Incorporation of [13C]- and [18O]-labelled acetates and
[methyl-13C]-methionine into thiomarinol A.
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pathways. A regular acetate incorporation pattern is observed in
the C1–C14 fragment of thiomarinol. A high level of 13C incor-
poration (5–6%) is observed at all seven expected positions in
the polyketide-derived moiety with high levels of 18O retention
(ca. 80%) at carbons 1, 5, 7 and 13 (Table 1). The 4- and 6-
hydroxyl groups are not labelled from 18O-acetate and are at
positions consistent with their introduction being via tailoring
enzymes using molecular oxygen. The 16-methylene (55%
enriched from [methyl-13C]methionine) and 17-methyl carbons
(40% enriched) are methionine derived consistent with the
presence of C-MeT domains in the rst and third extension
modules, and the 15-methyl is derived from the methyl of a
cleaved acetate unit consistent with it being derived via the
HMGS b-branch pathway as in pseudomonic acid A.
Biosynthetic origin of the side-chain
Interestingly the labelling pattern in the octanoate side chain
did not follow a standard polyketide labelling pattern. Whilst
expected head-to-tail incorporation of intact acetate units from
[1,2-13C2]acetate was observed for C10 to C40 (2% incorporation),
a lower level of incorporation was observed in C50 and C60 (1%)
and much lower into C70 and C80 (0.3%). [2-13C]-Acetate also
gave a similar pattern withmuch lower incorporation of 13C into
both C70 and C80 (2% compared to 7% in other acetate-derived
positions), and an intermediate level of enrichment (4%) at C60
(Table 1). [1-13C, 18O2]-Acetate gave incorporation levels of
13C
(6%) at carbons 10 and 30 as was observed elsewhere, but
incorporation into C50 was half this level and at C70 was negli-
gible. A low incorporation, ca. 1%, into C80 was observed. These
results suggest that a C4 precursor is likely to be the starter unit
for two rounds of FAS catalysed extension to give the octanoate
side-chain. The observed scrambling of acetate incorporation at
C70 and C80 suggested the possible involvement of a citric acid
(Krebs) cycle intermediate.
Feeding [2,3-13C2]succinate to cultures of wild-type Pseu-
doalteromonas SANK 73390 revealed an intact incorporation
conrmed by observation of a 13C–13C coupling of 34 Hz
between C60 and C70 (ca. 0.5% enrichment, Scheme 2, see insert
expansion in Fig. S10†) in accord with the proposed C4
precursor. A lower level of incorporation (0.15%) was also
observed elsewhere within the molecule resulting from degra-
dation of [2,3-13C2]succinate to [1,2-
13C2]acetate.
It is known that 4-hydroxybutyrate can be formed via
reduction of succinyl CoA.24 The overall results of acetate
incorporation are also consistent with this: acetate is incor-
porated intact into only carbons 3 and 4 of succinyl CoA
(Scheme S2, ESI†) which explains the signicant but lower
incorporation into C50/C60 of thiomarinol, presumably due to
dilution by a pool of endogenously derived Krebs Cycle
intermediate. Further cycling of labelled succinate would give
single labels at carbons 1 and 2 of succinyl CoA which explains
the lower levels of labelling from [2-13C]acetate into C70
and C80. To explain the low level of intact acetate labelling of
C70/C80, the conversion of succinyl CoA to symmetrical succi-
nate must be partially reversible so that ca. 30% of the succi-
nate is incorporated via this route. The low level of labelling at
C80 from [1-13C]acetate is completely consistent with this
hypothesis.
To further investigate the proposed C4 side-chain precursor,
[2,3-13C2]-4-hydroxybutyrate was prepared from [2,3-
13C2]succi-
nate via cyclisation to succinic anhydride, reduction to the
lactone with LiAlH4 followed by hydrolytic ring opening with
aqueous NaOH (Scheme S1†). Feeding [2,3-13C2]-4-hydroxy-
butyrate to cultures of the wild-type Pseudoalteromonas SANK
73390 showed a site-specic labelling (0.2%) of thiomarinol A at
C60, C70 conrming intact incorporation (Scheme 2, see insert
expansion in Fig. S12†).













1 166.1 2 (76) 5 (0.03)
2 114.3 2 (76) 7
3 160.8 2 (43) 5
4 72.4 2 (43) 7
5 76.2 2 (43) 6 (0.02)
6 63.8 2 (43) 7
7 69.6 2 (35) 6 (0.02)
8 42.2 2 (35) 7
9 31.8 2 (44) 6
10 127.7 2 (44) 7
11 134.1 2 (44) 6
12 43.1 2 (44) 7
13 69.2 2 (39) 6 (0.02)
14 20.0 2 (39) 7
15 15.7 2 7
16 64.2
17 15.7
10 171.8 2 (50) 6 (0.03)
20 34.6 2 (50) 7
30 24.9 2 (35) 6
40 28.4 2 (35) 7
50 28.3 1 (34) 3
60 25.3 1 (34) 4
70 28.2 0.3 (38) 2






a Percentage enrichment (>1 to nearest integer); signicant diﬀerences
from average values indicated in bold. b Average ratio of enriched (13C)
to enriched + isotopically shied (13C18O) signals is 1 : 4 except C-10
which is ca. 1 : 1, all values to nearest integer. c Spectra determined in
d6-DMSO, and d4-MeOH in which the 15- and 17-methyls appear
respectively at 14.9 and 15.2 ppm.
Scheme 2 Incorporation of [13C]-labelled succinate, 4-hydroxy-
butyrate and cystine into thiomarinol A.
This journal is © The Royal Society of Chemistry 2014 Chem. Sci., 2014, 5, 397–402 | 399






















































































Thus the biosynthetic origin of C50 to C80 is somewhat
similar to the situation presumed for 9-hydroxynonanoic in
mupirocin biosynthesis, where labelling studies are consistent
with a 3-hydroxypropionate starter unit, which then undergoes
three reductive chain elongations. 3-Hydroxypropionate can be
formed in bacteria by reduction of the thiolester of malonyl
CoA25 and both the mup and tml clusters show the presence of
genes encoding a malonyl/succinyl CoA dehydrogenase clus-
tered with an acyl CoA synthetase and an ACP.
Interestingly, the biosynthetic gene cluster for diﬃcidin,26
another trans-AT metabolite of Bacillus amyloliquefaciens, also
contains an oxo-acyl CoA reductase encoded by difE which as in
mupirocin/thiomarinol is grouped with an acyl CoA synthetase
and an ACP (difD and difC). In addition there is an adjacent
kinase (difB) which would be suitable for catalysing dehydration
of 3-hydroxypropionate to produce the acryl thiol ester required
to prime diﬃcidin chain elongation.
The retention of 18O label at C10 of thiomarinol A is slightly
less than half that at the other acetate-oxygen bearing positions.
This is consistent with C10 existing as the free carboxylate,
resulting in randomisation of the label between both carbox-
ylate oxygens, before ligation via an amide bond to the pyrro-
thine. Analysis of the structure of the pyrrothine moiety of
thiomarinol suggest that it is formed via two molecules of
cysteine. To gain evidence for this proposal, [2-13C]cystine was
prepared from ethyl [2-13C]pyruvate, (Scheme S2†) and fed to
WT Pseudoalteromonas. A high level of incorporation of 13C into
the C200 and C40 0 positions (16 and 20% respectively) conrmed
that the pyrrothine is indeed cysteine, and therefore NRPS,
derived (Scheme 2).
The biosynthetic gene cluster for holomycin biosynthesis in
Streptomyces clavuligerus has been isolated and a pathway from
cysteine proposed. This pathway involves initial dipeptide
formation followed by a series of oxidative cyclisations, the nal
step being acetylation of the free pyrrothine.18 To prove that the
pyrrothine moiety in thiomarinol is assembled and then
incorporated as an intact unit rather than being assembled on
marinolic acid, pyrrothine was synthesised as previously
described27 and fed to the DNRPS mutant strain of SANK 73390.
The mutant was prepared by a deletion in the holA gene
encoding the amino acid activation domain which, from
sequence analysis of the active site, is predicted to selectively
activate cysteine. As indicated above, the DNRPS mutant nor-
mally produces mainly marinolic acid. When cultures were
supplemented with pyrrothine, the normal WT phenotype was
restored indicating that Pseudoalteromonas takes the intact
pyrrothine as substrate (Scheme 3). Interestingly, the concen-
tration of the feeds was critical, with maximum restoration of
thiomarinol A production being observed at a pyrrothine
concentration of 20 mgml1. At concentrations of >80 mgml1,
no thiomarinol A was observed and production of marinolic
acid was also completely inhibited (Fig. S3, ESI†).
Novel acyl pyrrothines via mutasynthesis
Previous studies have shown that when TmlU, a putative amide
ligase is knocked out, the mutant strain produces no
thiomarinol but does produce marinolic acid and the full set of
xenorhabdins.20 The HolE analogue, ORF3483, from the hol-
omycin cluster in S. clavuligerus has been expressed and puri-
ed and it has been shown18 to act as an acyl transferase capable
of transferring acetyl and longer acyl groups to pyrrothine. Thus
it appears that the thiomarinol cluster has two ligases, TmlU
which forms the amide in thiomarinol, and HolE which links
pyrrothine to a wide range of acyl CoAs available in Pseu-
doalteromonas to produce the xenorhabdins.
To test if HolE can also transfer a range of non-endogenous
substrates, various short, medium and long chain fatty acids
and others with u-functionalized side chains, e.g. hydroxyl,
amino, carboxyl and phenyl were fed to the DPKS mutant
(Scheme 4). Some of these were incorporated with varying eﬃ-
ciencies, presumably aer conversion to their respective CoA
esters, sometimes aer catabolic chain shortening to give 19
and the novel acyl-pyrrothines 26–30.
The biosynthesis of thiomarinol A and related metabolites
The isolation of the minor metabolites 15–18 from both WT and
mutant strains and the incorporation of isotopically labelled
substrates can be rationalised as shown in Scheme 5. Marinolic
acid A 15 is produced by the DNRPS and DTmlU mutants, and is
present in trace amounts in the WT which suggests that it is both
a genuine biosynthetic product and intermediate in its own right
and is not produced as an artefact, e.g. as a degradation product
of thiomarinol A. The intermediacy of marinolic acid 15 was
conrmed by feeding it to the DPKS mutant whereupon, thio-
marinol production was restored (Fig. S19†). The amide 16 on the
other hand was only seen in the WT cultures which suggests that
it is formed by degradation of thiomarinol A, and is not formed
by, e.g. amidation of marinolic acid. This was further evidenced
by feeding thiomarinol A to the DPKS mutant when the presence
of both marinolic acid and marinolic amide in the crude extract
could be observed by LCMS. This suggests that the amide is
indeed a degradation product of thiomarinol.
The isolation of truncated metabolites marinolic acids A4
and A6, is consistent with the isotope labelling studies which
suggest that a C4 intermediate is added to the product of the
PKS, e.g. by trans-esterication. This would then be elongated to
Scheme 3 Feeding pyrrothine to the NRPS mutant gives thiomarinol A.
Scheme 4 Novel acyl-pyrrothines generated using the DNRPS
mutant.
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give an enzyme bound hexanoate analogue which would be
further elongated to give the completed octanoate side chain. In
the absence of the pyrrothine in the DNRPS mutant they would
be released either by enzymatic or spontaneous hydrolysis as
marinolic acids. We have previously shown that release of
assembly intermediates occurs when ux of intermediates
along the normal mupirocin pathway is impaired by a range of
targeted mutations of trans-acting and other tailoring genes.28
Similar mechanisms would allow leakage of marinolic acids A4
and A6 into the medium. It is signicant that this appears to be
more pronounced in the mutant than the WT. Truncated forms
of mupirocin and related metabolites with C7 and C5 hydroxy
acids have also been observed in both mutant strains and when
the quorum sensing regulation mechanism has been manipu-
lated to increase mupirocin production.29
Conclusions
Using a combination of genetic and isotopic labelling studies,
evidence has been presented for a mixed PKS-NRPS biosynthetic
pathway to the antibiotic thiomarinol A in Pseudoalteromonas sp.
SANK 73390. Particularly interesting features of the pathway
include assembly of the 8-hydroxyoctanoic acid side-chain, which
is generated via chain extension of a C4 precursor (4-hydroxy-
butyrate), and both marinolic acids A4 18 and A6 17 have been
isolated as minor metabolites from both wild-type and theDNRPS
mutant. There was a good incorporation of [13C]cystine into thi-
omarinol A and feeding studies with synthetic pyrrothine to the
DNRPS mutant are in accord with heterocycle assembly (HolA-D,
F-H) prior to intact incorporation into thiomarinol A (TmlU). A
further minor metabolite, marinolic amide 16, present in wild-
type but not the DNRPS mutant, is a degradation product of thi-
omarinol. Isotopic labelling studies indicate that the biosynthesis
of the C1–C17 fragment is analogous to that of pseudomonic acid,
a trans-AT modular PKS pathway with many fascinating and, as
yet, unexplained features and these studies lay the foundation for
a further understanding of the pathways to these compounds.
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